Climate Change Data

Missionpharma A/S

Climate Impact & Sustainability Data (2022-04 to 2023-03, 2023-04 to 2024-03)

Reporting Period: 2022-04 to 2023-03

Environmental Metrics

Renewable Energy Share:65% (across all locations)
Total Energy Consumption:394,000 kWh (solar)
Waste Generated:9.5 tons (pharmaceutical destruction)

ESG Focus Areas

  • Human Rights
  • Labour
  • Environment
  • Anti-corruption

Environmental Achievements

  • Installation of additional 100 kW solar power in India, reaching a total capacity of 400 kW, generating 394,000 kWh green energy and reducing CO2 emissions by 273 tons.
  • New warehouse in India built with environmentally friendly solutions.
  • Additional rainwater conservation tanks installed with a total capacity of 200,000 liters.

Social Achievements

  • Employment of a global Chief Human Resource Officer.
  • Global harmonisation of employee satisfaction survey resulting in a 94% satisfaction rate.
  • Sponsorship partnership with Mercy Ships, contributing to 32 life-saving operations in Africa.
  • CSR donations to local communities in India.

Governance Achievements

  • 100% of target group completed individual training in assigned digital compliance courses.
  • Intensified engagement of local compliance correspondents.
  • No observations of human rights infringement reported.

Climate Goals & Targets

Long-term Goals:
  • 50% reduction in group CO2 emission levels in 2030 (CFAO Group target)
Medium-term Goals:
  • Utilisation of 400 kW solar power to cover 60% of total electricity needs for warehousing and packing operations in India.
Short-term Goals:
  • Electricity savings of 20% in Lynge.
  • Establish complete CO2 consumption baseline.

Environmental Challenges

  • Minimising environmental impact from product life cycle, including manufacturers, carriers, freight forwarders, premises, and customers.
  • Maintaining high ethical standards and preventing corruption risks.
Mitigation Strategies
  • Implementing initiatives to reduce energy consumption and CO2 emissions.
  • Establishing key performance indicators for significant environmental aspects.
  • Implementing comprehensive vetting programmes for business relations.
  • Implementing new Group compliance policies to strengthen the fight against corruption.

Supply Chain Management

Supplier Audits: 39

Responsible Procurement
  • GMP audit programme assessing potential use of child labour and forced labour.

Climate-Related Risks & Opportunities

Reporting Standards

Frameworks Used: UN Global Compact

Certifications: ISO 9001, ISO 14001, GDP

UN Sustainable Development Goals

  • SDG 3
  • SDG 8
  • SDG 13

Missionpharma's activities contribute to these goals through improving access to healthcare, promoting decent work, and reducing environmental impact.

Awards & Recognition

  • No. 1 exporter of healthcare products in Kandla Special Economic Zone

Reporting Period: 2023-04 to 2024-03

Environmental Metrics

Renewable Energy Share:30% (of total warehousing, packaging and air conditioning needs in Kandla)

ESG Focus Areas

  • Environment
  • Social
  • Governance

Environmental Achievements

  • Reduced pharmaceutical destruction levels by 35% compared to the previous year.
  • Generated 432,000 kWh of green energy from 400 kW solar power installations in India, resulting in 305 tons of reduced CO2 emissions.
  • Achieved 16% electricity savings in Lynge due to LED lighting investments.

Social Achievements

  • 95% of employees globally rated Missionpharma as a great place to work.
  • Employed a full-time HR Manager in India.
  • Donated to Mercy Ships, enabling 39 surgeries.
  • Made CSR donations to local communities in India.

Governance Achievements

  • Full implementation of four new Group compliance policies and a whistleblowing procedure.
  • 100% of employees globally trained in new compliance policies.
  • Conducted 60 GMP audits.

Climate Goals & Targets

Medium-term Goals:
  • Evaluate and conclude on further expansion of solar panels in India.
Short-term Goals:
  • Maintain minimum 90% of shipped value with ISO 14001-certified International Freight Forwarders.
  • Continue to reduce pharmaceutical destruction levels relative to sales volumes.
  • Realize full-year effect on electricity savings in Lynge as a result of LED investments.

Environmental Challenges

  • Increased energy demands due to expanded warehousing capacity in India.
  • Balancing business goals with environmental effects across the value chain.
Mitigation Strategies
  • Continued investment in solar energy in India.
  • Use of ISO 14001-certified International Freight Forwarders for most shipments.
  • Improved procurement strategies and stock management to reduce pharmaceutical destruction.

Supply Chain Management

Supplier Audits: 60/year

Responsible Procurement
  • Comprehensive pre-qualification programme for manufacturers, including regular on-site GMP audits.

Climate-Related Risks & Opportunities

Reporting Standards

Frameworks Used: UN Global Compact

Certifications: ISO 9001, ISO 13485, ISO 14001

UN Sustainable Development Goals

  • 3
  • 8
  • 13
  • 17

Missionpharma's activities contribute to these goals through various initiatives detailed in the report.

Awards & Recognition

  • CFAO Best Safety Poster Award 2023